|
DPY19L4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.202340E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.654450E-02 |
| Normal-vs-Stage2 |
8.083900E-03 |
| Normal-vs-Stage3 |
2.565700E-04 |
| Normal-vs-Stage4 |
3.8599000000028E-05 |
| Stage1-vs-Stage2 |
3.112400E-01 |
| Stage1-vs-Stage3 |
5.793900E-02 |
| Stage1-vs-Stage4 |
4.098600E-03 |
| Stage2-vs-Stage3 |
7.318400E-01 |
| Stage2-vs-Stage4 |
2.622600E-01 |
| Stage3-vs-Stage4 |
3.209400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.755800E-04 |
| Normal-vs-AfricanAmerican |
2.052800E-01 |
| Normal-vs-Asian |
5.095500E-02 |
| Caucasian-vs-AfricanAmerican |
3.724200E-01 |
| Caucasian-vs-Asian |
4.243800E-01 |
| AfricanAmerican-vs-Asian |
7.950000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.435400E-04 |
| Normal-vs-Female |
3.520700E-03 |
| Male-vs-Female |
3.603400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.970100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.393100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.955700E-04 |
| Normal-vs-Age(81-100Yrs) |
9.635500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.594400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.172300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.858600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.795400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.496600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.497200E-03 |
| Classical-VS-Follicular |
7.697700E-02 |
| Classical-VS-Other |
5.301600E-01 |
| Classical-VS-Normal |
2.012000E-02 |
| Tall-VS-Follicular |
1.602050E-01 |
| Tall-VS-Other |
4.745000E-01 |
| Tall-VS-Normal |
6.11819999999375E-05 |
| Follicular-VS-Other |
9.705000E-01 |
| Follicular-VS-Normal |
1.599120E-03 |
| Other-VS-Normal |
1.365610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.881990E-03 |
| Normal-vs-N1 |
1.164370E-03 |
| N0-vs-N1 |
5.083200E-01 |
|
|
